NRC Health announced its Q3 2024 results, with revenue at approximately $35.8 million, a decrease from $37.9 million in the 2023 quarter. Earnings per diluted share were $0.24, also down from $0.32 in the previous year.
Revenue for the quarter was approximately $35.8 million, down from $37.9 million in Q3 2023.
Earnings per diluted share decreased to $0.24, compared to $0.32 in the same quarter last year.
Net indebtedness stood at approximately $50.2 million as of September 30, 2024.
The company returned approximately $11.5 million to stockholders through dividends and stock repurchases.
The press release contains forward-looking statements regarding future dividends, which are subject to risks and uncertainties as detailed in the company's filings with the Securities and Exchange Commission.
Analyze how earnings announcements historically affect stock price performance